NCT05988346View on ClinicalTrials.gov

Ghrelin and Diastolic Heart Function

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

January 1, 2022

Study Completion Date

March 1, 2022

Conditions
Diabetes Mellitus, Type 2Obesity, AbdominalDiastolic Dysfunction
Interventions
PROCEDURE

abdominal plastic intervention

According to international guidelines, authors will remove the superficial abdominal fat from the patients enrolled in the study.

Trial Locations (1)

80138

Celestino Sardu, Naples

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT05988346 - Ghrelin and Diastolic Heart Function | Biotech Hunter | Biotech Hunter